Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form ...

Cancer of unknown primary site encompasses a heterogeneous group of metastatic cancers with an unidentified primary site of origin. Putative site-specific therapy and empirical chemotherapy are acc ...

The team found that as prostate cancer cells transition to an alternate identity, PROX1 becomes more highly expressed. Their studies implicating PROX1 began by examining patient tumor biopsies ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form.

Josh Breen, who was diagnosed with stage 3 melanoma last year, will throw out the first pitch at Tuesday's Phillies' game as a part of Strike Out Cancer Night.

A Davie mom fighting a rare and rapidly spreading cancer is enrolled in a pioneering clinical trial at Memorial Cancer Institute that could save her life.

Macrophages are immune cells with a split personality: some fight tumors, while others help them grow. In breast cancer, most ...

They hope the tool could help doctors make decisions about how aggressively to treat patients for cancer and other chronic diseases.

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.

Middlesex County New cancer hospital with pinball machines, celebrity chefs aims to change patient care Updated: May. 14, 2025, 10:24 a.m. | Published: May. 13, 2025 ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.